Echocardiography During Ajmaline Test

Status Recruiting

Clinical Trial Summary

In this study the investigators analyse echocardiographic images before and during Ajmaline test. The purpose is to know if any echocardiographic modifications are present during either negative or positive Ajmaline testing.

Clinical Trial Description

The diagnosis of Brugada Syndrome is made when a type 1 pattern is present on the electrocardiogram (ECG), either spontaneously or after administration of a sodium channel blocker. For pathofysiological understanding, the investigators will analyse echocardiography images before and during the administration of Ajmaline. Comparing echocardiographies before and during negative Ajmaline test, will allow the investigators to indentify the effect of Ajmaline administration on cardiac function. The comparison between images of negative and positive Ajmaline tests will expose differences related to the occurence of a type 1 ECG. ;

Study Design

Related Conditions & MeSH terms

Brugada Syndrome

Clinical Trial Details

NCT number	NCT03491475
Study type	Observational
Source	Universitair Ziekenhuis Brussel
Contact	Esther Scheirlynck, MD
Phone	+3228012461
Email	esther.scheirlynck@uzbrussel.be
Status	Recruiting
Phase
Start date	March 26, 2018
Completion date	May 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05048602` - Drug-induced Brugada Syndrome Research Database
Terminated	`NCT00701077` - DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome	Phase 3
Recruiting	`NCT03435393` - Ripple Mapping for Epicardial Mapping of Brugada Syndrome	N/A
Active, not recruiting	`NCT02933437` - The Response To Ajmaline Provocation in Healthy Subjects	Phase 2
Active, not recruiting	`NCT04257994` - Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
Recruiting	`NCT05685134` - Invasive and Clinical Features in Patients With Brugada Syndrome Undergoing Catheter Ablation	N/A
Recruiting	`NCT04580992` - Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective Trial
Completed	`NCT02641431` - Epicardial Ablation in Brugada Syndrome	N/A
Completed	`NCT03182777` - Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies	N/A
Completed	`NCT00292032` - Registry of Unexplained Cardiac Arrest
Completed	`NCT04124237` - Long Term Monitoring for Risk of Sudden Death
Completed	`NCT02344277` - Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients
Completed	`NCT04650009` - Physical Activity in Children With Inherited Cardiac Diseases
Recruiting	`NCT04808193` - European Perioperative Brugada Survey	N/A
Recruiting	`NCT05521451` - Clinical Cohort Study - TRUST
Recruiting	`NCT03485508` - The Brugada Syndrome: a Follow-up Study
Completed	`NCT00702117` - Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias	Phase 4
Recruiting	`NCT02704416` - Ablation in Brugada Syndrome for the Prevention of VF	N/A
Recruiting	`NCT03775954` - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Completed	`NCT04420078` - Brugada Ablation of VF Substrate Ongoing MultiCenter Registry